Your fact-checks will appear here
Neuropeptide analogue of gastric inhibitory polypeptide
Shed/ShedRx and Eden (and related branded options like LillyDirect) emerge repeatedly as top online Tirzepatide providers, with , while Eden and branded channels offer mixed packages including Zepboun...
GLP-1 receptor agonists are powerful weight‑loss drugs that reliably reduce fat but can be associated with reductions in lean mass proportional to overall weight loss, while other peptides—chiefly gro...
Clinical trials and systematic reviews consistently show that stopping GLP‑1 receptor agonists such as semaglutide is commonly followed by clinically meaningful weight regain — often returning a large...
There is no evidence in the supplied reporting that any “pink gelatin” or “pink salt gelatin” weight‑loss products are FDA‑approved as drugs; the viral “pink salt gelatin trick” is presented as a soci...
Available reporting on Flash Burn is mixed: multiple independent review sites state Flash Burn is not FDA-approved and note that dietary supplements are not FDA-approved before sale (e.g., NiraHealthy...
Burn Jaro’s marketing and many product reviews present it as a non‑stimulant, mitochondria‑supporting weight‑loss supplement with low rates of cardiovascular side effects, but some product description...
Randomized trials show two contrasting pathways to diabetes remission and weight loss: intensive very low calorie diets (VLCDs) can produce drug‑off remission with lasting benefit in protocolized prog...
Bydureon (exenatide extended‑release) is a once‑weekly injectable GLP‑1 receptor agonist approved as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes in adults and certai...
Dual GIP/GLP‑1 agonists like tirzepatide reduce weight and improve multiple cardiometabolic risk factors that plausibly lower heart‑failure events in obese patients, particularly HFpEF, via hemodynami...
Systematic reviews find that most over‑the‑counter “fat‑burner” supplements produce little or no clinically meaningful weight loss, while a small set of nutraceuticals show modest, peer‑reviewed benef...
Randomized trials and pooled analyses show semaglutide delivers larger average reductions in HbA1c and body weight than many other GLP‑1 receptor agonists (GLP‑1RAs), with head‑to‑head meta‑analysis f...
GLP‑1 receptor agonists are prescription drugs that mimic an endogenous gut hormone to alter brain and gut circuits, slow gastric emptying, improve glycemic control and produce clinically meaningful, ...
Elon Musk has been repeatedly and falsely linked to dietary supplements marketed to treat diabetes or blood‑sugar issues—advertisers have used deepfaked videos and fake endorsements to push products l...
Tirzepatide is a prescription-only medication in the United States, so legally it cannot be bought over the counter; obtaining it online requires a valid prescription and appropriate clinical oversigh...
Proven approaches to appetite control and modest weight loss combine behavioral strategies, evidence-based diets, physical activity, and—when appropriate—medical therapies; no single method fits every...
The most reliable pathways for obtaining tirzepatide in 2026 are FDA-approved brand channels supplied by Eli Lilly (Mounjaro for diabetes, Zepbound for weight loss), established telehealth platforms t...
Tirzepatide is a prescription, once‑weekly injectable dual GIP/GLP‑1 receptor agonist studied across multiple phase 3 programs (SURPASS for diabetes and SURMOUNT for obesity) and meta‑analyses, produc...
Laellium’s publicly reported side-effect profile is uniformly mild: manufacturer and review sites repeatedly state “no reported side effects” and emphasize a gentle, stimulant-free formula . However, ...
In December 2025, the most-discussed drinks for weight loss in U.S. coverage are water and low‑calorie beverages (including plain water and sparkling water), protein/meal‑replacement shakes, green tea...
Out‑of‑pocket monthly costs for brand tirzepatide (Mounjaro/Zepbound) commonly exceed $1,000 but many telehealth programs, compounded options, and manufacturer savings can lower real cash prices into ...